VBI Vaccines Inc (VBIV)
0.5743
-0.03
(-4.19%)
USD |
NASDAQ |
Apr 26, 16:00
0.5743
0.00 (0.00%)
After-Hours: 16:27
VBI Vaccines Revenue (TTM): 8.682M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.682M |
September 30, 2023 | 8.122M |
June 30, 2023 | 1.815M |
March 31, 2023 | 1.441M |
December 31, 2022 | 1.082M |
September 30, 2022 | 0.87M |
June 30, 2022 | 0.66M |
March 31, 2022 | 0.456M |
December 31, 2021 | 0.631M |
September 30, 2021 | 0.714M |
June 30, 2021 | 0.905M |
March 31, 2021 | 0.947M |
December 31, 2020 | 1.061M |
September 30, 2020 | 1.471M |
June 30, 2020 | 1.82M |
March 31, 2020 | 2.276M |
December 31, 2019 | 2.221M |
September 30, 2019 | 4.331M |
June 30, 2019 | 3.943M |
March 31, 2019 | 3.537M |
December 31, 2018 | 3.355M |
September 30, 2018 | 0.872M |
June 30, 2018 | 0.806M |
March 31, 2018 | 0.916M |
December 31, 2017 | 0.865M |
Date | Value |
---|---|
September 30, 2017 | 0.801M |
June 30, 2017 | 0.889M |
March 31, 2017 | 0.627M |
December 31, 2016 | 0.548M |
September 30, 2016 | 0.401M |
June 30, 2016 | 0.224M |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.456M
Minimum
Mar 2022
8.682M
Maximum
Dec 2023
2.287M
Average
1.441M
Median
Mar 2023
Revenue (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 7.098M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |